Check for GLP-1 Agonist Use in Patients Admitted With Gallbladder Problems

You'll hear more about a possible link between gallbladder disease and GLP-1 agonists...such as liraglutide (Victoza, etc) or exenatide (Byetta, etc).

The latest evidence suggests that about one in 357 patients taking liraglutide or exenatide over about 3 years will be hospitalized for bile duct or gallbladder disease...compared to patients on other diabetes meds.

We know that patients with diabetes already have a higher risk of bile duct and gallbladder disease. But GLP-1 agonists may increase this risk...possibly by causing rapid weight loss in some patients.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals